<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Pharmacol Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Pharmacol. Rev</journal-id>
<journal-id journal-id-type="hwp">pharmrev</journal-id>
<journal-id journal-id-type="pmc">Pharmacol Rev</journal-id>
<journal-id journal-id-type="publisher-id">PharmRev</journal-id>
<journal-title-group>
<journal-title>Pharmacological Reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">0031-6997</issn>
<issn pub-type="epub">1521-0081</issn>
<publisher>
<publisher-name>The American Society for Pharmacology and Experimental Therapeutics</publisher-name>
<publisher-loc>Bethesda, MD</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29263209</article-id>
<article-id pub-id-type="pmc">5738717</article-id>
<article-id pub-id-type="publisher-id">PHARMREV_014456</article-id>
<article-id pub-id-type="doi">10.1124/pr.117.014456</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies</article-title>
<alt-title alt-title-type="short">Ion Channels in Genetic Epilepsy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Oyrer</surname>
<given-names>Julia</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maljevic</surname>
<given-names>Snezana</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scheffer</surname>
<given-names>Ingrid E.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berkovic</surname>
<given-names>Samuel F.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petrou</surname>
<given-names>Steven</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Reid</surname>
<given-names>Christopher A.</given-names>
</name>
</contrib>
<aff id="aff1">The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia (J.O., S.M., I.E.S., S.P., C.A.R.); Department of Medicine, Austin Health, University of Melbourne, Heidelberg West, Melbourne, Australia (I.E.S., S.F.B.); and Department of Paediatrics, University of Melbourne, Royal Children’s Hospital, Melbourne, Australia (I.E.S.)</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Sexton</surname>
<given-names>Patrick M.</given-names>
</name>
<role>ASSOCIATE EDITOR</role>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Address correspondence to:</bold> Dr. Christopher A. Reid, <addr-line>Florey Neuroscience Institutes, University of Melbourne, Parkville, Victoria 3010, Australia.</addr-line> E-mail: <email>christopher.reid@florey.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>1</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>70</volume>
<issue>1</issue>
<fpage>142</fpage>
<lpage>173</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="pr.117.014456.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>Epilepsy is a common and serious neurologic disease with a strong genetic component. Genetic studies have identified an increasing collection of disease-causing genes. The impact of these genetic discoveries is wide reaching—from precise diagnosis and classification of syndromes to the discovery and validation of new drug targets and the development of disease-targeted therapeutic strategies. About 25% of genes identified in epilepsy encode ion channels. Much of our understanding of disease mechanisms comes from work focused on this class of protein. In this study, we review the genetic, molecular, and physiologic evidence supporting the pathogenic role of a number of different voltage- and ligand-activated ion channels in genetic epilepsy. We also review proposed disease mechanisms for each ion channel and highlight targeted therapeutic strategies.</p>
</abstract>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="429"></ref-count>
<page-count count="32"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name> DJS Export </meta-name>
<meta-value>v1</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>